ÂÜÀòÂÒÂ×

Justin Zelin is a Director in Biotechnology Equity Research Analysis. Prior to their current role, Justin held positions at BTIG, B. Riley Financial, Canaccord Genuity, SVB Leerink, and Oppenheimer & Co. Their experience includes roles as an Adjunct Faculty and Research Assistant at Harvard University, as well as positions focused on infectious disease vaccine research and development at Agenus, Broad Institute, Beth Israel Deaconess Medical Center, and Brigham and Women's Hospital. Justin holds a Master's degree in Biotechnology and a Bachelor's degree in Biology from Harvard University.